Patients Partner Content The Multilayered Impact of Rare Disease on Relationships Pharma marketers: rare conditions can impact all types of relationships and one's social life.
Patients Partner Content Maximizing Consumer Engagement with People with Rare Disease Dive into three overarching challenges marketers in the rare disease space often face.
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.